Zoledronate for Bone Health After Stem Cell Transplant
Treatments studied
Part of Blood & lymphatic, Bones, joints & muscles clinical trials.
This trial tests if a bone-strengthening medicine called zoledronate can help prevent bone problems in children and teens who have had a stem cell transplant. It may be an option for patients with low bone density or those who develop graft-versus-host disease after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 18 years old.
- You are getting a stem cell transplant and have low bone density, or you have already had a stem cell transplant and developed graft-versus-host disease (a complication from the donor cells).
- You do not have Fanconi anemia or other conditions that increase cancer risk from radiation.
- You have not taken bone-strengthening medicines like zoledronate or alendronate before.
- Your vitamin D level is not very low (below 20 ng/mL).
- You do not have active infections, kidney problems, or other bone diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a bone-strengthening drug called zoledronic acid can help people with congenital dyserythropoietic anemia (CDA), a rare type of anemia. It's for adults with moderate to severe anemia who may also need blood transfusions.
This trial tests if zoledronate, a medicine that strengthens bones, can reduce pain in children with CRMO (a condition causing repeated bone inflammation). It compares zoledronate to a placebo (inactive treatment) to see if it helps after 12 weeks.
This study checks how the body handles a medicine called zoledronic acid in people with kidney disease who are on dialysis and have weak bones (osteoporosis). It may help doctors find the right dose to safely treat bone loss in this group.
This study looks at how a bone-strengthening measure (bone mineral density and bone structure) changes over time after an allogeneic stem cell transplant for acute myeloid leukemia (AML). It may help doctors better understand transplant-related bone effects and how to monitor them.
This real-world study looks at how the medicine zoledronic acid affects bone-related problems in people with breast cancer that has spread to the bone. It may help reduce events like fractures or other bone complications by protecting bone health.
This trial tests whether taking vitamin A and D after a stem cell transplant can help improve recovery. It is for people with certain blood cancers who have a matched donor and are in remission or have low disease activity.
Hear when a new Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.